Option Care Health’s (OPCH) Outperform Rating Reaffirmed at Barrington Research

Option Care Health (NASDAQ:OPCH)‘s stock had its “outperform” rating reaffirmed by analysts at Barrington Research in a research note issued on Wednesday, Benzinga reports. They currently have a $40.00 price objective on the stock. Barrington Research’s price target indicates a potential upside of 34.41% from the stock’s previous close.

Separately, JMP Securities upped their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a report on Monday, September 30th.

Option Care Health Stock Performance

OPCH stock opened at $29.76 on Wednesday. Option Care Health has a one year low of $26.11 and a one year high of $34.63. The firm has a market cap of $5.17 billion, a price-to-earnings ratio of 19.58, a PEG ratio of 2.21 and a beta of 1.29. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.36 and a current ratio of 1.76. The firm has a 50-day simple moving average of $31.07 and a two-hundred day simple moving average of $30.11.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $0.30 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.03. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The firm had revenue of $1.23 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same quarter last year, the firm earned $0.63 EPS. The business’s quarterly revenue was up 14.8% on a year-over-year basis. On average, equities analysts forecast that Option Care Health will post 1.22 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Option Care Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Harbor Capital Advisors Inc. increased its holdings in shares of Option Care Health by 317.9% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock valued at $2,670,000 after purchasing an additional 73,312 shares in the last quarter. Comerica Bank increased its holdings in Option Care Health by 6.5% in the first quarter. Comerica Bank now owns 760,915 shares of the company’s stock valued at $25,521,000 after buying an additional 46,639 shares in the last quarter. Janus Henderson Group PLC raised its position in shares of Option Care Health by 182.9% in the first quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock worth $7,617,000 after acquiring an additional 146,837 shares during the period. Edgestream Partners L.P. raised its position in shares of Option Care Health by 96.8% in the second quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock worth $9,736,000 after acquiring an additional 172,845 shares during the period. Finally, XTX Topco Ltd purchased a new stake in shares of Option Care Health during the 2nd quarter worth about $973,000. 98.05% of the stock is owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.